Cargando…
Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721
In this paper, we prepared doxorubicin-loaded folic acid-functionalized pH-sensitive photothermal therapy (PTT) traceable hollow mesoporous silica nanoparticles (DOX-HPCF) as a drug carrier for liver cancer treatment. According to TEM characterization, hollow mesoporous silica nanoparticles (HMSN) a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034047/ https://www.ncbi.nlm.nih.gov/pubmed/32009475 http://dx.doi.org/10.1080/10717544.2020.1718801 |
_version_ | 1783499800085266432 |
---|---|
author | Cao, Yue Wu, Chao Liu, Ying Hu, Lili Shang, Wenjing Gao, Zhanshan Xia, Nan |
author_facet | Cao, Yue Wu, Chao Liu, Ying Hu, Lili Shang, Wenjing Gao, Zhanshan Xia, Nan |
author_sort | Cao, Yue |
collection | PubMed |
description | In this paper, we prepared doxorubicin-loaded folic acid-functionalized pH-sensitive photothermal therapy (PTT) traceable hollow mesoporous silica nanoparticles (DOX-HPCF) as a drug carrier for liver cancer treatment. According to TEM characterization, hollow mesoporous silica nanoparticles (HMSN) are monodispersed spherical particles with hollow structure. In vitro drug release experiments showed that HPCF exhibited pH-sensitive release. Cell uptake experiments showed that HPCF was successfully absorbed by SMMC-7721 cells. In addition, DOX-HPCF significantly inhibited the proliferation of SMMC-7721 cells, and the near-infrared (NIR) light group showed a more obvious inhibitory effect. In vivo anti-tumor experiments showed that DOX-HPCF-assisted PTT inhibited tumor growth significantly. Therefore, HPCF is a promising photothermotherapy carrier for the treatment of liver cancer. |
format | Online Article Text |
id | pubmed-7034047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-70340472020-03-03 Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721 Cao, Yue Wu, Chao Liu, Ying Hu, Lili Shang, Wenjing Gao, Zhanshan Xia, Nan Drug Deliv Research Article In this paper, we prepared doxorubicin-loaded folic acid-functionalized pH-sensitive photothermal therapy (PTT) traceable hollow mesoporous silica nanoparticles (DOX-HPCF) as a drug carrier for liver cancer treatment. According to TEM characterization, hollow mesoporous silica nanoparticles (HMSN) are monodispersed spherical particles with hollow structure. In vitro drug release experiments showed that HPCF exhibited pH-sensitive release. Cell uptake experiments showed that HPCF was successfully absorbed by SMMC-7721 cells. In addition, DOX-HPCF significantly inhibited the proliferation of SMMC-7721 cells, and the near-infrared (NIR) light group showed a more obvious inhibitory effect. In vivo anti-tumor experiments showed that DOX-HPCF-assisted PTT inhibited tumor growth significantly. Therefore, HPCF is a promising photothermotherapy carrier for the treatment of liver cancer. Taylor & Francis 2020-02-03 /pmc/articles/PMC7034047/ /pubmed/32009475 http://dx.doi.org/10.1080/10717544.2020.1718801 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Cao, Yue Wu, Chao Liu, Ying Hu, Lili Shang, Wenjing Gao, Zhanshan Xia, Nan Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721 |
title | Folate functionalized pH-sensitive photothermal therapy traceable hollow
mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect
of doxorubicin in the hepatoma cell line SMMC-7721 |
title_full | Folate functionalized pH-sensitive photothermal therapy traceable hollow
mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect
of doxorubicin in the hepatoma cell line SMMC-7721 |
title_fullStr | Folate functionalized pH-sensitive photothermal therapy traceable hollow
mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect
of doxorubicin in the hepatoma cell line SMMC-7721 |
title_full_unstemmed | Folate functionalized pH-sensitive photothermal therapy traceable hollow
mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect
of doxorubicin in the hepatoma cell line SMMC-7721 |
title_short | Folate functionalized pH-sensitive photothermal therapy traceable hollow
mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect
of doxorubicin in the hepatoma cell line SMMC-7721 |
title_sort | folate functionalized ph-sensitive photothermal therapy traceable hollow
mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect
of doxorubicin in the hepatoma cell line smmc-7721 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034047/ https://www.ncbi.nlm.nih.gov/pubmed/32009475 http://dx.doi.org/10.1080/10717544.2020.1718801 |
work_keys_str_mv | AT caoyue folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721 AT wuchao folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721 AT liuying folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721 AT hulili folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721 AT shangwenjing folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721 AT gaozhanshan folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721 AT xianan folatefunctionalizedphsensitivephotothermaltherapytraceablehollowmesoporoussilicananoparticlesasatargeteddrugcarriertoimprovetheantitumoreffectofdoxorubicininthehepatomacelllinesmmc7721 |